Jul 24, 2025, 09:19 AM by

START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem.

Jul 24, 2025, 01:00 AM by User Not Found

Bio-IT World | A groundbreaking biotech collaboration in Switzerland has successfully integrated nine molecular analysis platforms to create a comprehensive tumor profiling system that predicts optimal cancer treatments—showcasing how next-generation sequencing can be enhanced through multiomics approaches for transformative clinical outcomes.

Jul 23, 2025, 09:49 AM by

Jul 23, 2025, 09:48 AM by

I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing our partnership with the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine to co-host the BioFestival on October 17, 2025. This event is designed to support emerging scientists, promote interdisciplinary collaboration, and foster disruptive innovation in the life sciences. The BioFestival will feature interactive science booths, professional networking, and the BioDisruptor Grant Competition, where students will compete for over $9,000 in cash prizes and $20,000 in Zymo Research product credits and services. We believe this event will be of significant interest to your readers, especially those focused on life sciences, academic research, biotechnology innovation, and student-driven discovery. You can view the full press release here: https://www.zymoresearch.com/blogs/press-releases/university-of-maryland-biofestival

Jul 23, 2025, 09:48 AM by

Linus Health Showcases Digital Breakthroughs to Advance Early Detection and Personalization in Brain Health at AAIC 2025

Jul 23, 2025, 01:00 AM by User Not Found

Bio-IT World | To support patient privacy while providing data accessibility for organizations, the National Health Service (NHS) England with IQVIA developed NHS PET (Privacy Enhancing Technology) as a secure, scalable solution for patient data. The work earned NHS and IQVIA one of four Innovative Practices Awards at this year’s Bio-IT World Conference & Expo—an honor the judges christened the “Respect the Patient Award”.

Jul 22, 2025, 08:44 AM by

I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing the launch of Endura™ Tn5 Transposase, a next-generation solution for NGS library preparation workflows. Endura™ Tn5 is specifically engineered for enhanced stability and consistent performance in NGS-based applications. This innovation addresses long-standing challenges in Tn5 technologies, including enzyme instability and variability in fragmentation results. We believe this launch will be of significant interest to your readers in genomics, molecular biology, sequencing technologies, and life science research. You can view the full press release here: https://www.zymoresearch.com/blogs/press-releases/zymo-research-endura-tn5-transposase We would greatly appreciate it if you would consider sharing this news with your readers. If you require any additional information, high-resolution images, or would like to arrange an interview with one of our experts, please do not hesitate to reach out. I look forward to the opportunity to collaborate with your team. Thank you for your time and consideration.

Jul 22, 2025, 01:00 AM by User Not Found

Bio-IT World | The National Institute of Standards and Technology (NIST) has released the first cancer cell line in its Genome in a Bottle (GIAB) consortium. The new resource features a pancreatic cancer tumor cell line along with corresponding normal tissue samples, all obtained with explicit patient consent for public genomic data sharing.

Jul 21, 2025, 09:17 AM by

PhenoTips, a leading provider of precision medicine software, announces today the appointment of Parker Lachance as VP of Revenue. Parker Lachance brings to PhenoTips an extensive history scaling start-ups through sales, marketing, and customer success strategy, most recently as Vice President of Revenue Operations at Smile Digital Health.

Jul 18, 2025, 01:00 AM by User Not Found

Bio-IT World | Imagine sitting down for a routine checkup and learning you could prevent one of the most devastating diseases of our time before it ever occurs. For many families, diagnosis arrives only after noticeable confusion or memory loss disrupts daily life. By that point, much of the brain has already been damaged, and options for slowing decline are limited.

Jul 17, 2025, 08:13 AM by

Dear GenomeWeb Editorial Team, I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing the upcoming BioFestival at Harvard University, taking place on October 18, 2025. We believe this event will resonate strongly with your audience, especially those engaged in life sciences, academic research, and biotech innovation. The press release highlights Zymo Research’s partnership with Harvard to celebrate disruptive research, foster academic-industry collaboration, and promote sustainable scientific innovation. With over $9,000 in cash awards and $20,000 in research funding at stake, this event empowers students to advance their research and connect with leaders in the life science community. We invite you to read the full press release here: https://www.zymoresearch.com/blogs/press-releases/harvard-university-biofestival

Jul 17, 2025, 08:13 AM by

Huateng Pharma spotlights N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7), a versatile compound used in drug synthesis and biomedical research. Known for its role in HDAC inhibitor development, the compound also shows potential in metal chelation, antioxidant activity, and enzyme modulation. Huateng Pharma supports ongoing pharmaceutical innovation by providing high-purity intermediates like this for global research and development.

Jul 17, 2025, 08:13 AM by

New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapies

Jul 17, 2025, 08:13 AM by

Jul 17, 2025, 08:13 AM by

This momentum reflects the company’s strong role as a trusted partner to major laboratories worldwide as it helps them to unlock the clinical, operational, and financial value of AI-driven pathology at scale.

Jul 16, 2025, 09:41 AM by

Jul 16, 2025, 09:41 AM by

BIOPHARMA PEG has received FDA Drug Master File (DMF) numbers for two PEG-based intermediates: mPEG-pALD 20K (DMF 040600) and HZ-PEG-HZ (1K) (DMF 041864). These compounds are commonly used in drug conjugation, controlled release, and nanoparticle modification applications, and their DMF listings provide regulatory support for pharmaceutical development.

Jul 16, 2025, 09:41 AM by

Jul 16, 2025, 09:41 AM by

Qureight’s deep-learning image biomarkers and clinical data analytics platform used to analyse enrolled idiopathic pulmonary fibrosis (IPF) patient data, supporting efficacy outcome and expansion to larger global patient studies

Jul 16, 2025, 09:41 AM by

Vector Laboratories and Navinci launched the Glysite™ Explorer in situ PLA Glycan Detection Kit, the first commercially available tool to spatially detect protein glycosylation in FFPE tissues and fixed cells. By combining Vector’s validated lectins with Navinci’s in situ PLA technology, the kit offers researchers a streamlined, reproducible way to study glycan-protein proximity and gain deeper insight into disease biology and biomarker discovery.